Uripan Xr 30 Tablets

Uripan Xr 30 Tablets

Description:

Uripan Xr 30 Tablets (Uripan 5 mg 30 tabs) is a prescription urinary antispasmodic medicine containing oxybutynin, an antimuscarinic agent that relaxes the bladder muscle. It is used to manage symptoms of overactive or unstable bladder such as urinary urgency, increased frequency, urge incontinence, and certain cases of nocturnal enuresis (bedwetting) in children as directed by a physician. By reducing involuntary bladder contractions, Uripan Xr helps improve bladder control and quality of life in patients with urinary incontinence and related conditions.

Indications:

• Treatment of urinary incontinence associated with overactive or unstable bladder.
• Management of urinary urgency and increased urinary frequency due to detrusor overactivity.
• Symptomatic relief in patients with unstable bladder conditions, including urge incontinence.
• Adjunctive treatment of nocturnal enuresis (bedwetting) in children when recommended and supervised by a physician.

Active Ingredients / Key Components:

• Oxybutynin hydrochloride – 5 mg per tablet (antimuscarinic urinary antispasmodic).
• Other inactive ingredients/excipients: Not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not exceed the recommended dose.
• Typical adult dosing for overactive bladder is usually 5 mg taken 2–3 times daily, but the exact dose, frequency, and duration must be individualized by the doctor. Extended-release (xr) regimens may differ.
• Tablets should be swallowed whole with a sufficient amount of water. Do not crush or chew unless your doctor or pharmacist specifically instructs otherwise.
• Can be taken with or without food; if gastric upset occurs, taking it with food may help.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Do not stop treatment abruptly without medical advice, especially if used for chronic bladder conditions.
• Use in children for nocturnal enuresis or bladder instability must be strictly under pediatric specialist supervision, with dose adjusted according to age and weight.

Clinical Benefits:

• Helps reduce involuntary bladder muscle spasms by blocking muscarinic (m1, m2, m3) receptors and exerting direct spasmolytic effects on bladder smooth muscle.
• Decreases urinary urgency and frequency, improving bladder capacity and control.
• Reduces episodes of urge incontinence, helping minimize accidental urine leakage and associated discomfort.
• May assist in reducing nocturnal enuresis (bedwetting) episodes in selected pediatric patients when used under medical supervision.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to oxybutynin or any component of the product.
• Contraindicated in patients with urinary retention, severe decreased gastrointestinal motility, gastric retention, uncontrolled narrow-angle glaucoma, or myasthenia gravis.
• Use with caution in elderly patients, those with hepatic or renal impairment, autonomic neuropathy, ulcerative colitis, or gastroesophageal reflux disease.
• May cause drowsiness, dizziness, or blurred vision; avoid driving, operating machinery, or performing tasks requiring alertness until you know how the medicine affects you.
• May reduce sweating and increase the risk of heat prostration in high temperatures; avoid overheating and stay well hydrated.
• Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy only if clearly needed and prescribed.
• Consult your doctor before use if breastfeeding; oxybutynin may pass into breast milk and a risk–benefit assessment is required.
• Inform your doctor about all other medications you are taking, especially other anticholinergic drugs, antihistamines, tricyclic antidepressants, antiarrhythmics, or medications that may cause urinary retention or constipation.
• Consult your doctor before use if you have liver disease, kidney disease, glaucoma, gastrointestinal obstruction, severe constipation, or heart disease.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dry mouth, constipation, nausea, abdominal discomfort, blurred vision, dizziness, drowsiness, dry eyes, and decreased sweating.
• Other possible effects: headache, urinary retention or difficulty urinating, tachycardia (fast heartbeat), confusion (especially in elderly), or mood changes.
• Serious side effects that require immediate medical attention include: severe allergic reactions (rash, itching, swelling of face/lips/tongue, difficulty breathing), severe constipation or abdominal pain, inability to urinate, vision changes, chest pain, or severe dizziness/fainting.
• If any side effects are persistent, bothersome, or worsening, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Serving size: As prescribed (typically 1 tablet per dose).
• Count: 30 tablets per pack.
• Form: Tablet (oral use).
• Active ingredient strength: oxybutynin hydrochloride 5 mg per tablet.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.